196 related articles for article (PubMed ID: 25402978)
1. How the environment shapes cancer genomes.
Pfeifer GP
Curr Opin Oncol; 2015 Jan; 27(1):71-7. PubMed ID: 25402978
[TBL] [Abstract][Full Text] [Related]
2. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
3. Mutational spectra of human cancer.
Pfeifer GP; Besaratinia A
Hum Genet; 2009 Jun; 125(5-6):493-506. PubMed ID: 19308457
[TBL] [Abstract][Full Text] [Related]
4. Modelling Mutation Spectra of Human Carcinogens Using Experimental Systems.
Zhivagui M; Korenjak M; Zavadil J
Basic Clin Pharmacol Toxicol; 2017 Sep; 121 Suppl 3():16-22. PubMed ID: 27754614
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
[TBL] [Abstract][Full Text] [Related]
6. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
7. Mutational and epigenetic signatures in cancer tissue linked to environmental exposures and lifestyle.
Perduca V; Omichessan H; Baglietto L; Severi G
Curr Opin Oncol; 2018 Jan; 30(1):61-67. PubMed ID: 29076965
[TBL] [Abstract][Full Text] [Related]
8. Experimental investigations of carcinogen-induced mutation spectra: Innovation, challenges and future directions.
Melki PN; Korenjak M; Zavadil J
Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503195. PubMed ID: 32522347
[TBL] [Abstract][Full Text] [Related]
9. [Mapping DNA damage to understand somatic mutagenesis].
Lacoste S; Rochette PJ; Drouin R
Med Sci (Paris); 2010 Feb; 26(2):193-200. PubMed ID: 20188052
[TBL] [Abstract][Full Text] [Related]
10. Comparison of induced and cancer-associated mutational spectra using multivariate data analysis.
Lewis PD; Manshian B; Routledge MN; Scott GB; Burns PA
Carcinogenesis; 2008 Apr; 29(4):772-8. PubMed ID: 18296683
[TBL] [Abstract][Full Text] [Related]
11. Understanding mutagenesis through delineation of mutational signatures in human cancer.
Petljak M; Alexandrov LB
Carcinogenesis; 2016 Jun; 37(6):531-40. PubMed ID: 27207657
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput next-generation sequencing-based method for detecting the mutational fingerprint of carcinogens.
Besaratinia A; Li H; Yoon JI; Zheng A; Gao H; Tommasi S
Nucleic Acids Res; 2012 Aug; 40(15):e116. PubMed ID: 22735701
[TBL] [Abstract][Full Text] [Related]
13. Geographic variation of mutagenic exposures in kidney cancer genomes.
Senkin S; Moody S; Díaz-Gay M; Abedi-Ardekani B; Cattiaux T; Ferreiro-Iglesias A; Wang J; Fitzgerald S; Kazachkova M; Vangara R; Le AP; Bergstrom EN; Khandekar A; Otlu B; Cheema S; Latimer C; Thomas E; Atkins JR; Smith-Byrne K; Cortez Cardoso Penha R; Carreira C; Chopard P; Gaborieau V; Keski-Rahkonen P; Jones D; Teague JW; Ferlicot S; Asgari M; Sangkhathat S; Attawettayanon W; Świątkowska B; Jarmalaite S; Sabaliauskaite R; Shibata T; Fukagawa A; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Bartlett JMS; Albert M; Phouthavongsy L; Ashton-Prolla P; Botton MR; Silva Neto B; Bezerra SM; Curado MP; Zequi SC; Reis RM; Faria EF; de Menezes NS; Ferrari RS; Banks RE; Vasudev NS; Zaridze D; Mukeriya A; Shangina O; Matveev V; Foretova L; Navratilova M; Holcatova I; Hornakova A; Janout V; Purdue MP; Rothman N; Chanock SJ; Ueland PM; Johansson M; McKay J; Scelo G; Chanudet E; Humphreys L; de Carvalho AC; Perdomo S; Alexandrov LB; Stratton MR; Brennan P
Nature; 2024 May; 629(8013):910-918. PubMed ID: 38693263
[TBL] [Abstract][Full Text] [Related]
14. Advances in carcinogenesis: a historical perspective from observational studies to tumor genome sequencing and TP53 mutation spectrum analysis.
Soussi T
Biochim Biophys Acta; 2011 Dec; 1816(2):199-208. PubMed ID: 21791238
[TBL] [Abstract][Full Text] [Related]
15. Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.
Besaratinia A; Pfeifer GP
FASEB J; 2010 Aug; 24(8):2612-9. PubMed ID: 20371617
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
17. Environmental and occupational causes of cancer: a call to act on what we know.
Clapp RW; Howe GK; Jacobs MM
Biomed Pharmacother; 2007 Dec; 61(10):631-9. PubMed ID: 17905564
[TBL] [Abstract][Full Text] [Related]
18. [SENTIERI Project: discussion and conclusions].
Pirastu R; Ricci P; Comba P; Bianchi F; Biggeri A; Conti S; Fazzo L; Forastiere F; Iavarone I; Martuzzi M; Musmeci L; Pasetto R; Zona A; Crocetti E
Epidemiol Prev; 2014; 38(2 Suppl 1):125-33. PubMed ID: 24986501
[TBL] [Abstract][Full Text] [Related]
19. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier M; Hussain SP; Caron de Fromentel C; Hainaut P; Harris CC
IARC Sci Publ; 2004; (157):247-70. PubMed ID: 15055300
[TBL] [Abstract][Full Text] [Related]
20. Environmental exposures and mutational patterns of cancer genomes.
Pfeifer GP
Genome Med; 2010 Aug; 2(8):54. PubMed ID: 20707934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
